Society for Inherited Metabolic Disorders Annual Meeting

遗传性代谢紊乱学会年会

• 批准号: 7749902
• 负责人: NICOLA LONGO
• 金额: $ 1.8万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-14 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7749902
• 关键词: Affect; American; Area; Arthritis; Award; Biochemistry; Blindness; Cerebral Palsy; Clinical; Clinical Trials; Congresses; Country; Development; Diabetes Mellitus; Disease; Failure; Functional disorder; Funding; Goals; Growth; Heart Diseases; Hepatic; Inborn Errors of Metabolism; Individual; Inherited; International; Kidney; Mass Spectrum Analysis; Medical Genetics; Mental Retardation; Metabolic Diseases; Minority; Molecular; Neonatal Screening; Neuromuscular Diseases; Patient Care; Physicians; Recruitment Activity; Research; Research Personnel; Scholarship; Societies; Source; Specialist; Time; Training; Travel; United States National Institutes of Health; Woman; abstracting; college; effective therapy; meetings; programs

DESCRIPTION (Provided by Applicant): The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2009 and 2010. The 2009 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in San Diego, CA, while the 2010 meeting will be held in Albuquerque, NM, in coordination with the annual meeting of the American College of Medical Genetics. Inborn errors of metabolism (IEM) are an important cause of mental retardation, cerebral palsy, neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure, and blindness. As the wide clinical and molecular spectrum of these disorders is being elucidated, in part fueled by the development of tandem mass spectroscopy and the rapid expansion of newborn screening programs, the number of affected individuals is now known to be much larger than originally recognized. In addition, therapies are available for some conditions, yet few clinical trials have been performed to evaluate their efficacy. Thus, much remains to be done to better understand these severe disorders and develop effective treatments for them. For the U.S. to remain preeminent in this important area of research, it is essential to attract young investigators into the field. One effective mechanism to achieve this goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field and develop scientific ties to other established investigators. The SIMD meeting is held annually and participation, especially by young investigators, has been steadily increasing each year. The availability of NIH travel awards has been a major reason for this increase. Trainees seeking funding are required to submit an abstract describing original research to be presented at the meeting. The organizers anticipate submission of 40 to 50 abstracts for presentation at the annual meetings in the U.S. (2010) with two to three times that number for the international meeting (2009). Applications for travel awards will be competitively reviewed four months prior to the meeting, with the goal of making 25 annual awards of $1,000 each. Additional funds will be solicited from private sources. Women and minority applicants will be actively recruited. PROJECT NARRATIVE: The Society for Inherited Metabolic Disorders (SIMD) meeting will help to train new physicians to take care of patients with disorders of the body's biochemistry. There are very few such specialists in the country, and providing travel funds for new trainees to meet and present their research encourages them to remain in the field.

DESCRIPTION (Provided by Applicant): The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2009 and 2010. The 2009 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in San Diego, CA, while the 2010 meeting will be held in Albuquerque, NM, in coordination with the annual meeting of the American College of Medical Genetics. 天生的新陈代谢错误（IEM）是智力低下，脑瘫，神经肌肉疾病，心脏疾病，肝功能障碍，关节炎，糖尿病，生长失败和失明的重要原因。 由于这些疾病的广泛临床和分子光谱正在阐明，部分是由于串联质谱的发展和新生儿筛查程序的快速扩张所推动的，因此现在已知受影响的个体的数量比最初被识别的大得多。 此外，在某些情况下可以使用疗法，但很少进行临床试验来评估其功效。 因此，要更好地理解这些严重的疾病并为它们开发有效的治疗措施还有很多工作要做。 要使美国在这一重要的研究领域保持杰出，必须吸引年轻的研究人员进入该领域。 实现这一目标的一种有效机制是为他们提供参加SIMD会议的机会，在那里他们可以探索该领域并与其他知名研究人员建立科学联系。 SIMD会议每年举行，尤其是年轻的调查人员的参与，每年都在稳步增加。 NIH旅行奖的可用性一直是造成这种增长的主要原因。 要求资助的学员必须提交一项摘要，描述要在会议上进行的原始研究。 组织者预计，在美国的年度会议（2010年）中将提交40至50个摘要，以供介绍，国际会议的数字是2到三倍（2009年）。 旅行奖的申请将在会议前四个月进行竞争性审查，目的是每人25年奖励奖励1,000美元。 额外的资金将从私人来源征集。 妇女和少数民族申请人将被积极招募。 项目叙述：遗传代谢疾病协会（SIMD）会议将有助于培训新的医生，以照顾患有人体生物化学疾病的患者。 该国很少有这样的专家，并为新学员提供旅行资金，并介绍他们的研究，鼓励他们留在该领域。